To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 626.00 |
Bid | 622.00 |
Ask | 628.00 |
Change | 4.00 (0.64%) |
Volume | 43,914 |
Open | 634.00 |
High | 634.00 |
Low | 624.00 |
Prev. Close | 622.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.50m |
Market Capitalisation | £234.75m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 34 |
---|---|
Vol. Sold | 22,670 |
Sold Value | £140.81k |
Vol. Bought | 924 |
Bought Value | £5.82k |
PE Ratio | 37.2841 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.505% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
31-May-24 | 15:51:25 | 628.00 | 15,000 | Unknown* | 622.00 | 628.00 | 94.20k | O Ordinary Delayed publication |
31-May-24 | 16:35:21 | 626.00 | 47 | Sell* | 626.00 | 634.00 | 294.22 | UT Uncrossing Trade |
31-May-24 | 16:18:36 | 624.00 | 500 | Sell* | 624.00 | 630.00 | 3,120 | A Automatic Execution |
31-May-24 | 16:18:36 | 624.00 | 715 | Sell* | 624.00 | 630.00 | 4,462 | A Automatic Execution |
31-May-24 | 16:18:28 | 624.7746 | 333 | Sell* | 624.00 | 630.00 | 2,080 | O Ordinary |
31-May-24 | 16:12:37 | 628.68 | 2 | Buy* | 626.00 | 630.00 | 12.57 | O Ordinary |
31-May-24 | 15:50:22 | 627.9091 | 292 | Sell* | 626.00 | 630.00 | 1,833 | O Ordinary |
31-May-24 | 15:27:34 | 626.4786 | 48 | Sell* | 626.00 | 630.00 | 300.71 | O Ordinary |
31-May-24 | 15:23:13 | 630.00 | 300 | Buy* | 624.00 | 630.00 | 1,890 | A Automatic Execution |
31-May-24 | 15:22:08 | 624.9907 | 1,293 | Sell* | 624.00 | 630.00 | 8,081 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |